INTRODUCTION
Dried blood or "Guthrie" spots are taken from children born in developed countries for newborn screening for a number of metabolic disorders including phenylketonuria (PKU) (1) and genetic testing using PCR-based assays (2) . However, the utility of such samples for DNA methylation analysis has remained unclear due to the general requirement of microgram quantities of genomic DNA as starting material (3) . More recently, bisulfite sequencing on limited amounts of DNA from microdissected samples has been demonstrated (4) . Bisulfite sequencing is capable of discriminating methylated cytosine from unmethylated cytosine in genomic DNA (3) . However, traditional bisulfite-based DNA modification has the inherent problem of DNA degradation due to the destructive nature of the modification process (5) . Often, this has deleterious effects on the ability to successfully generate test PCR products for analysis. Furthermore, there is evidence for DNA fragmentation over time with storage of dried blood spots (6) , and this can also influence the efficiency of any downstream, PCR-based applications. More recently, matrixassisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry has been used as a means of high-throughput DNA methylation analysis (7) and could potentially be used to analyze such samples en masse. The degree to which these factors will influence the utility of bisulfite-based methylation analysis on Guthrie spots has not previously been tested.
Here, we aim to investigate the utility of DNA methylation analysis by bisulfite PCR-based DNA sequencing and SEQUENOM analysis on dried blood spot Guthrie samples. We analyzed the methylation status of two gene promoters, predicted to be either methylated [DNA methyltransferase 3- (Table 1) . Where indicated, modification of the recommended protocol for dried blood spots was also carried out according to manufacturer's instructions.
Sequence tagged site (STS) marker PCR amplification of D6S510 and D6S265 (primers listed in Table 2 ) was performed on 1 μL extracted genomic DNA. PCR Mastermix (Promega) was used to amplify the STS markers, and the conditions used for amplification are as follows: denaturation at 95°C for 2 min, followed by 25 cycles of 95°C for 30 s, 53°C for 30 s, and 72°C for 30 s.
The yield of genomic DNA from each extraction method was determined by spectrophotometry (Nanodrop, Wilmington, DE, USA) and was further characterized by using a serial 2-fold standard curve and absolute quantitative PCR using primers to D6S510 and SYBR GreenER qPCR Supermix (Invitrogen, Carlsbad, CA, USA) using the following amplification conditions: polymerase activation at 95°C for 30 s, 53°C for 10 min, followed by 40 cycles of 95°C for 15 s, 60°C for 60 s. Quantitative PCR was analyzed using an ABI 7300 (Applied Biosystems, Foster City, CA, USA). Traditional bisulfite PCR was performed using a two-round heminested strategy. Bisulfite primers were targeted to the VDR and DNMT3L gene promoter (Table 2) . PCR Mastermix (Promega) was used for amplification, and the conditions were 95°C for 2 min, followed by 30 cycles of 95°C for 30 s, 52°C for 30 s, 72°C for 90 s, and a final extension at 72°C for 7 min. The first round of PCR was performed using the Bi_VDR1F and Bi_VDR1R primers with 1 μL amplification reaction transferred to a second round of PCR using the Bi_VDR1F and Bi_VDR2R primers. Similarly, Bi_DNMT3L1F and Bi_DNMT3L1R were used for the first round of PCR, and Bi_DNMT3L2F and Bi_DNMT3L1R were used for the second round of PCR.
The products were subjected to cloning and DNA sequencing by ligation into pGEMT-Easy vector (Promega) with transformation into DH5-α Escherichia coli cells. Positive clones were selected for automated fluorescent sequencing (see Figure 2 , A and B) 
A methylation titration was constructed with 0%, 25%, 50%, 75%, and 100% DNA methylation ratios using genomic DNA isolated from a leukemia cell line, REH (Accession no. CRL8286; ATCC, Manassas, VA, USA), which we have found to be unmethylated at the H19 differentially methylated region (DMR) and in vitro-methylated human genomic DNA (Millipore). Each titration (100 ng) was bisulfite-converted using the MethylEasy Xceed Bisulfite Xceed Bisulfite Xceed Modification kit (Human Genetic Signatures) according to manufacturer's instructions and subjected to PCR amplification of the H19 imprinted locus (Sqnm_163bp1F and Sqnm_163bp1R) ( Table 2) for SEQUENOM mass spectrometry analysis.
Products derived for SEQUENOM mass spectrometry were subjected to the homologous MassCLEAVE reaction chemistry (hMC; SEQUENOM, San Diego, CA, USA) according to manufacturer's instructions. The T-cleavage reaction was performed on the samples that were then spotted using the SEQUENOM Nanodispenser onto a SpectroCHIP for subsequent analysis.
RESULTS AND DISCUSSION
Here, we have investigated the possibility of performing bisulfite-mediated DNA methylation analysis by either bisulfite PCR and sequencing or mass spectrometry on DNA derived from dried blood spots. We tested a range of commercially available DNA extraction kits for purifying genomic DNA from fresh and dried blood for downstream PCR applications and applied this to DNA methylation analysis. Furthermore, we have evaluated a number of commercially available bisulfite-based conversion kits alongside the in-house bisulfite conversion method (3) on their utility for DNA methylation analysis on dried blood Guthrie samples.
By spectrophotometry, all methods of genomic DNA extraction revealed generally very low quality (absorption 
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260/280 ratios ranging from 0-0.5) and low yield of genomic DNA from the dried blood spots, which may be due to carryover contaminants from the blood (6) ( Table 1) . Genomic DNA was detected from all extraction methods by standard D6S510 and D6S265 microsatellite PCR ( Figure  1A) . By quantitative PCR, all extraction methods yielded between 0.025-100 ng of total genomic DNA ( Table 1) . Our comparisons reveal that genomic DNA extracted with the ChargeSwitch Forensic DNA Purification kit yielded the highest amounts of genomic DNA ( Table 1) . The genomic DNA extracted from these kits was then subjected to bisulfite modification, PCR, and sequencing. Products were successfully obtained on bisulfite-converted DNA generated using the MethylEasy kit with DNA extracted using Instagene Matrix, ReadyAmp DNA Purification System, and ChargeSwitch Forensic DNA Purification kits, while other bisulfite conversion methods failed to yield analyzable products (Table 1 and Figure  1B ). Conversion artifacts (detection of non-CpG methylation after bisulfite PCR and sequencing) were observed in clones derived from DNA extracted by the Instagene Matrix and ReadyAmp kits (Table 1 ) making these methods of extraction inappropriate for subsequent DNA methylation analysis (data not shown). From this result, we have determined that genomic DNA extracted from dried blood spots using the ChargeSwitch Forensic DNA Purification kit and subsequently bisulfite-modified using the MethylEasy kit to be suitable for downstream DNA methylation analysis.
We then tested this method on dried blood Guthrie spots prepared up to 5 years ago, that were stored according to standard procedures for newborn screening laboratories, with similar success to freshly prepared samples (Figure 2, A and B ). Furthermore, we tested a second-generation bisulfite modification kit (MethylEasy Xceed kit) that considerably reduced modification time from 16 h to 45 min with similar success (Table 1) .
Using this approach, we observed that the VDR promoter was unmethylated ( Figure 1C) in all dried blood spots tested and was consistent with ubiquitous VDR expression in normal tissue (8) . In contrast, the DNMT3L promoter was observed to be methylated in the same samples consistent with previous data, suggesting a highly restricted expression profile for DNMT3L and gene regulation by a mechanism that includes promoter hypermethylation (10) .
We then subjected the same aged samples to SEQEUNOM MassArray EpiTYPER analysis using primers targeting the H19/IGF2 imprinted region (Table 2 and Figure 3A) (9) . A standard titration of DNA methylation was generated using premixed ratios of unmethylated DNA to in vitromethylated human genomic DNA. One hundred nanograms of these titrations were then subjected to the same bisulfite treatment and PCR before being analyzed by SEQUENOM EpiTYPER software. The expected fragmentation and analyzable CpG sites/units are shown in Figure 3A . Two CpG units ( Figure 3A , units 1 and 2) were not analyzed, as these fragments fell outside the analysis mass window range. The remaining CpG units (units 3-7 and 8) were called by EpiTYPER for the titration samples, and the two aged Guthrie samples were analyzed. The methylation ratios analyzed for the titration were within the manufacturer's specifications (5% coefficient of variation) and generally agree with the premixed ratios of DNA methylation. DNA methylation was also analyzed from the aged Guthrie spots described above and showed an average methylation ratio of analyzed CpG units across the entire product of 0.37 and 0.45 ( Figure 3B ). This observation is in keeping with recently published observations of the same locus using the same methods on more readily available and abundant specimens including blood (11) .
In this study, we have demonstrated the utility of bisulfite-based DNA methylation analysis of DNA extracted from dried blood Guthrie spots. We have demonstrated that the combination of genomic DNA extraction using the ChargeSwitch Forensic DNA Purification kit with subsequent bisulfite modification using the MethylEasy kit yields DNA of sufficient quantity and quality for amplification and DNA sequencing of test genomic regions of interest. DNA extracted from all kits tested was of sufficient quality and yield for general genomic PCR ampli- We have determined that the DNA isolated in this manner is of sufficient quality and quantity for downstream bisulfite PCR-mediated DNA methylation analyses, including DNA sequencing and SEQUENOM MassArray EpiTYPER analysis. We have shown that it is possible to detect unmethylated and methylated gene promoters by cloning and sequencing and that is possible to detect imprinted regions from such samples using SEQUENOM. From the titration results, SEQUENOM would be the method of choice to evaluate regions that are not completely methylated or not completely unmethylated, because it is not prone to potential bias that could arise from PCR cloning and sequencing (4) .
The successful demonstration of DNA methylation analysis from archived blood spots will greatly facilitate future population-based epigenetic studies that may wish to examine retrospectively the association of specific epigenetic modifications at birth, with later health outcomes. Using such samples will provide a unique opportunity to investigate the role of epigenetics on the developmental origins of health and disease (DOHaD) (12) . By demonstrating the ability to analyze DNA methylation from dried blood Guthrie spots, we have expanded their current use to include DNA methylation analyses. This also has implications on planning and establishing biospecimen collections for future cohort studies (13) that may look into the role of epigenetics, as dried blood spots are more amenable to storage at room temperature and transport between laboratories. Although bisulfite PCR and sequencing is considered the gold standard for DNA methylation analysis, this methodology will be applicable to other bisulfite-based assays, such as methylation-specific PCR (14) , combined bisulfite restriction analysis (COBRA) (15) , and others (reviewed in Reference 16) . Not only will this allow researchers to link DNA methylation profile at birth to later disease, but also offers the opportunity for prospective collection of dried blood Guthrie spots for future DNA methylation analyses.
